PODCAST

Pulmonary Medicine

ReachMD

science & medicine medicine

All Episodes

00:00:00

What Does #FlattenTheCurve Mean in the Age of COVID-19?

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Caitlin Rivers, PhD, MPH What is #FlattenTheCurve? Caitlin Rivers, senior scholar at the Center for Health Security talks to Dr. Josh Sharfstein about this response strategy, what it means for you, and how staying home can help ensure that everyone who needs healthcare in an outbreak will be able to get it. Published March 17, 2020

00:00:00

Can Antibodies Be Used to Treat or Prevent COVID-19?

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Arturo Casadevall, MD, PhD Is there potential for using antibodies generated by people who have recovered from COVID-19 to prevent infection and treat those who are sick? Dr. Josh Sharfstein talks to Arturo Casadevall, chair of Department of Molecular Microbiology and Immunology at the Bloomberg School of Public Health, about a landmark 1934 case where antibodies helped stopped a measles outbreak. Published March 17, 2020

00:00:00

Ethical Dilemmas Posed by COVID-19

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Jeffrey Kahn, MD Guest: Nancy E. Kass, ScD Is it right to publicly disclose information about people who get sick with COVID-19? What are society’s obligations to people who are quarantined? Is it time to start thinking about how to allocate critical healthcare resources in case this epidemic stretches the healthcare system beyond its capacity to care for everyone? Dr. Josh Sharfstein speaks with renowned ethicists Jeffery Kahn and Nancy Kass,

00:00:00

How Nursing Homes & First Responders Can Address the...

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Professor Lucy Wilson Dr. Lucy Wilson, professor of Emergency Health Services at University of Maryland Baltimore County, talks with Dr. Josh Sharfstein about why the Seattle outbreak is an important bellwether for the rest of the country in terms of protecting vulnerable populations and what facilities and first responders can do to control and stop outbreaks like COVID-19. Published March 13, 2020

00:00:00

Tom Inglesby Answers Your COVID-19 Questions

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Thomas V. Inglesby, MD Can people without symptoms spread COVID-19? Can children get COVID-19? Should you cancel an upcoming gathering? Are school closures helpful? If you’ve had COVID-19, are you immune? Are men more affected than women? Dr. Tom Inglesby from the Center for Health Security answers these and some of the most asked questions. Published March 13, 2020

00:00:00

How Public Health Can Serve the Communities &...

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Georges Benjamin, MD Weak points in the U.S.’s health and social policies—like paid sick leave and universal health coverage—disproportionately affect underserved communities. COVID-19 may present added challenges for these populations. Dr. Josh Sharfstein talks to Dr. Georges Benjamin, executive director of the American Public Health Association, about public health’s role in preventing communities from being left behind. Published March 12,

00:00:00

From Global to Local: How Local Health Departments...

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Gabor Kelen, MD What role do local health departments play in outbreaks, and how are they preparing for COVID-19? As Commissioner of the Cuyahoga County Board of Health in Ohio, Terry Allan is responsible for the well-being of over 850,000 people. Allan talks to Dr. Josh Sharfstein about public trust and the importance of open information sharing and how ongoing relationship building and past experience help set the stage for protecting people in

00:00:00

A Systems Approach to COVID-19 Preparedness

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Terry Allan Why the director of Hopkins’ Office of Critical Event Preparedness is preparing but not panicking: Dr. Gabor Kelen, Director of the Johns Hopkins Office of Critical Event Preparedness and Response (CEPAR) talks to Dr. Josh Sharfstein about what’s contributing to public fears about COVID-19, how the institution assesses what actions to take, and his one piece of advice for people experiencing mild symptoms. Published March 10, 2020

00:00:00

How Are Hospitals Preparing for COVID-19?

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Lisa Maragakis, MD COVID-19 presents new challenges for health care providers in the midst of respiratory virus season. Dr. Lisa Maragakis, Senior Director of Infection Prevention at Johns Hopkins University School of Medicine, talks to Dr. Josh Sharfstein about standard precautions, protecting hospital staff while ensuring coverage, how previous outbreaks have laid some groundwork to address this one, and what you can do to help. Published March

00:00:00

Your COVID-19 Questions Answered

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Jennifer Nuzzo, MD Is hand sanitizer effective? Will this spread throughout the US? Should I cancel my upcoming travel plans? Can COVID-19 tests tell the difference between someone who has had the virus and someone who currently has it? Are face masks effective? Jennifer Nuzzo of the Johns Hopkins Center for Health Security answers these and some of the most asked questions. Published March 6, 2020

00:00:00

Unlocking the Secrets of COVID-19

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Andrew Stanley Pekosz, PhD Tune in for an interview with Professor Andrew Pekosz of the Johns Hopkins Bloomberg School of Public Health, an expert in the basic science of respiratory viruses, including influenza and SARS. Dr. Pekosz shares what’s known and what is yet to be discovered about the novel coronavirus. Published March 5, 2020

00:00:00

Understanding the Spread of COVID-19

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Justin Lessler, PhD Dr. Josh Sharfstein interviews infectious disease epidemiologist Dr. Justin Lessler on the features of viruses that lead to worldwide contagion, how COVID-19 compares with the flu in terms of speed, and where the evidence now points for this novel coronavirus. Dr. Justin Lessler is an Associate Professor in Epidemiology. Dr. Josh Sharfstein is the Vice Dean of the Johns Hopkins Bloomberg School of Public Health and former

00:00:00

COVID-19: Global Preparedness, Misinformation, &...

Pulmonary Medicine ·

2020/03/26

Host: Joshua Sharfstein, MD Guest: Jennifer Nuzzo, MD Guest: Tara Kirk Sell, PhD, MA Guest: Lauren M. Sauer, MS With COVID-19 beginning to spread via community transmission in the U.S. and the WHO raising its risk assessment to “very high,” experts from the Johns Hopkins School of Public Health and Johns Hopkins University School of Medicine offer insights on the growing global public health concern. Featuring Dr. Jennifer Nuzzo and Dr. Tara Kirk Sell of the Johns Hopkins

00:00:00

Separating Fact from Fiction: Novel Coronavirus Myths

Pulmonary Medicine ·

2020/02/07

Host: Mario R. Nacinovich, Jr., MSc Guest: Charles P. Gerba, MD The novel coronavirus outbreak that began in late 2019 may be the first global epidemic pronounced in the social media age, with myths and misinformation populating just as quickly and frequently as new cases. But is there any truth behind these claims? Here to shed light on this global health crisis is microbiologist Dr. Charles Gerba.

00:00:00

The Harsh Truth Behind the Vaping Epidemic

Pulmonary Medicine ·

2020/01/15

Host: Paul Doghramji, MD Guest: David H. Peyton, Ph.D. The vaping epidemic is becoming more and more concerning, but could new research prompt people to quit? To find out, Dr. Paul Doghramji speaks with Dr. David Peyton about his recent study that challenges the claim that vaping devices take less of a toll on our health than tobacco smoking.

00:00:00

Latest Updates in Treating Pneumonia

Pulmonary Medicine ·

2018/12/21

Host: Mario R. Nacinovich, Jr., MSc Guest: Kalin Clifford, PharmD Focusing on hospital-acquired and ventilator-associated pneumonia in older adults, Mario Nacinovich is joined by Dr. Kalin Clifford at the American Society of Consultant Pharmacists Annual Meeting. Together they dive deep into these two types of pneumonia to reveal new guidelines and the latest treatment options.

00:00:00

The Real Cost of Smoking: Medical, Financial, and...

Pulmonary Medicine ·

2018/03/26

Host: Brian P. McDonough, MD, FAAFP Tobacco use accounts for nearly half a million deaths in the U.S. each year and is the leading cause of lung cancer, according to the American Lung Association. However, the economic and societal costs of smoking are also staggering. Every year, Americans spend more than $300 billion, which includes both medical care and lost productivity. Unfortunately, some people will have to pay more depending on the state in which they live. Host Dr. Brian

00:00:00

FDA Review: Adding LABAs to ICS Treatment Does Not...

Pulmonary Medicine ·

2018/01/04

The FDA announced that a review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side effects than treatment with ICS alone. A link to the full communication detailing information for health care professionals and the Data Summary can be found at www.fda.gov/DrugSafetyCommunications. Released 12/20/2017

00:00:00

Rethinking Nicotine: The Campaign to Break the...

Pulmonary Medicine ·

2017/08/25

Host: Brian P. McDonough, MD, FAAFP Cigarette smoking is one of the leading cause of preventable death in North America, an unfortunate statistic that is rapidly replicating across the rest of the world. The World Health Organization (WHO) predicts based on current trends that cigarette smoking will kill a billion people this century. But what can be done to reverse this trend? Host Brian McDonough talks with David Sweanor, Adjunct Professor of Law, and Chair of the advisory committee

00:00:00

FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung...

Pulmonary Medicine ·

2017/07/28

FDA medical oncologists discuss the approval of osimertinib for EGFR mutation-positive non-small cell lung cancer. Released July 28, 2017

242 results

Pulmonary Medicine

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事